InvestorQ : Is Metropolis IPO worth subscribing?
Isha Tharwani made post

Is Metropolis IPO worth subscribing?

Answer
user profile image
ananya Sing answered.
1 year ago


Metropolis is a leading company in its field of diagnostics and it plans to focus on business-to-customer (B2C) expansion. If we look into the operational or the core function, it has an approximately 3,480 clinical laboratory tests and 524 profiles, as of March 31, 2018. This wide network covers 197 Indian Cities and five locations outside India.

The company is floating its 1.37cr shares to the public and is out for subscription from 3rd April to 5 April 2019. The price range is between Rs 877–880 per share with a face value of Rs 2. The minimum bid lot for is 17 which means that a subscriber has to buy a minimum of 17 shares in one go at the price of Rs  877–880 per share. Share reservation for retail investors is 35%. It will be listed on both BSE and NSE.

Metropolis business model is more similar to Dr. LalPathlabs and so the peer comparison with Dr. lalPathlabs can be done by the investor. The chairman of Metropolis Healthcare Sushil Shah said “We are growing at a decent pace and generating good free cash flow. With the IPO, around 50-60% debt at the holding company level would be gone. It is also easier to raise funds when an entity is listed. Therefore, as and when a good opportunity comes up, we would be better prepared to crack the deal.”

This Initial Public Offering (IPO) will have equity shares ad an offer or sale from promoter Dr. Sushil Kanubhai Shah and investor CA Lotus Investments stakes. So far the company seems to have a good track and intention to list. If you are ready to be invested in the company for a longer-term then its worth to subscribe.


user profile image
1 year ago


It is worth subscribing, I too have subscribed. The subscription has reached 9% in one day.


user profile image
1 year ago


Metropolis IPO that closed on 5 April had an expected experience, as it was over-subscribed by 5.8 times. Yeah, you heard right. The issue size of 7.662 million shares received bids for 44 million shares. It will be listed at BSE and NSE on 15 April 2019.

This Initial Public Offering (IPO) has equity shares that consist of an offer for sale from promoter Dr. Sushil Kanubhai Shah and investor CA Lotus Investments stakes.